Browse the evidence

The implementation of a pharmacist-led weight management clinic resulted in an estimated cost savings of $101,985.66.

Pharmacist involvement can lead to significant cost savings in weight management programs.

Females tended to lose more weight (Mean = 9.75) than males (Mean = 8.41).

Practitioners may consider gender differences when designing weight-loss interventions.

The semaglutide group mostly showed higher RSFC after the intervention, while the placebo group mostly showed lower RSFC in a selection of investigated ROIs.

This suggests that semaglutide may influence RSFC positively, but the clinical significance remains uncertain.

The animal-based, ketogenic diet led to increased blood ketones of ~3 mM, which is thought to suppress appetite.

Practitioners may consider the appetite-suppressing effects of ketogenic diets due to increased ketone levels.

The impact of substantial weight loss on mortality is marked in those dying of noncardiovascular causes, specifically cancer.

Substantial weight loss may increase mortality risk from noncardiovascular causes, such as cancer.

High carbohydrate intake is associated with a higher risk of dementia (HR 1.48 (95%CI: 1.15-1.91)), while low carbohydrate intake is not significantly associated.

Practitioners should consider advising older adults to moderate their carbohydrate intake to potentially reduce dementia risk.

Moderate intakes of carbohydrate, fat, and protein are associated with the lowest risk of incident dementia.

Practitioners should encourage older adults to maintain a balanced intake of macronutrients to potentially lower dementia risk.

There were no significant differences between groups for the remaining outcomes, although a small effect size favoring TRAD was observed for the middle region of the pectoralis major (g = -0.25).

Practitioners should note that while TRAD may have a slight advantage, it is not statistically significant for all outcomes.

Obesity is the predominant public health nutrition problem in developed countries such as the United States.

Public health initiatives should prioritize obesity prevention strategies.

Nutritional interventions can increase fatty acid availability and rates of fat oxidation during exercise.

Implementing specific nutritional strategies may help improve fat oxidation during exercise.

Dietary manipulations can alter macronutrient availability and muscle gene expression.

Dietary choices can significantly impact muscle function and metabolism.

Discontinuation rates were strongly associated with copayment amount, increasing from 41% in the lowest quintile to 51% in the highest quintile.

Financial considerations significantly impact patient adherence to semaglutide treatment.

A higher carbohydrate quality index (CQI) is associated with greater micronutrient consumption adequacy in Iranian adults.

Encouraging higher CQI may enhance overall nutrient adequacy in dietary practices.

Minimally invasive bariatric surgeries, endoscopic procedures, fecal microbiota transplants (FMTs), and pharmaceuticals like GLP-1 receptor agonists show promising results for obesity treatment.

Practitioners should consider these innovative treatment options for obesity management.

Diabetes management is being transformed by continuous glucose monitoring (CGM) systems and closed-loop insulin delivery.

Healthcare providers should adopt CGM systems and closed-loop delivery for improved diabetes management.

Bariatric surgery is the most cost-effective definitive treatment for all classes of obesity.

Healthcare systems should prioritize bariatric surgery as a treatment option for obesity.

Participants enrolling during program periods with access to a larger number of stores had ≤14.5% absolute higher redemption rates and 5-fold greater likelihood of shopping each month than those enrolled with fewest locations.

Increasing the number of stores available for produce prescription programs may enhance redemption rates and shopping frequency.

Redemption rates increased over time for participants in the program, rising from 31% in month 1 to 88% in month 24.

Longer participation in produce prescription programs is associated with significantly higher redemption rates.

Effects on gastric emptying appeared additive when BI 1820237 was combined with low-dose liraglutide.

Combining BI 1820237 with liraglutide may enhance effects on gastric emptying, which could be relevant for treatment strategies.

Some people with HIV treated with antiretroviral therapy gain unhealthy amounts of weight and develop consequences of obesity.

Healthcare providers should monitor weight changes in PWH on ART.

There is a strong need for multimodal therapeutic approaches to address obesity.

Therapists should implement diverse strategies to effectively manage obesity.

The combination of long-acting PYY analogs with a GLP-1 receptor agonist resulted in superior blood glucose lowering and greater body weight loss compared to GLP-1 alone.

Suggests a potential strategy for enhanced diabetes and obesity treatment.

Co-agonism of the glucagon and GLP-1 receptors improves glycemia in people with diabetes and obesity.

Practitioners may consider glucagon and GLP-1 receptor co-agonists as a treatment option for improving glycemia.

There are no indications of additional risk for people with HIV using liraglutide and semaglutide.

Liraglutide and semaglutide can be considered safe for use in HIV patients without additional risk.